Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
33 NOK | -0.30% |
|
+0.61% | -10.08% |
Jun. 25 | Orion Obtains License to Market Navamedic's Parkinson's Disease Drug in Europe | MT |
Jun. 24 | Navamedic ASA and Orion Corporation Sign License & Supply Agreement for Flexilev in Europe | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.08% | 53.95M | |
+55.55% | 816B | |
+41.47% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.96% | 238B | |
+0.98% | 222B | |
+13.40% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- NAVA Stock
- News Navamedic ASA
- Navamedic Raises Takeover Offer for Sensidose, Agrees to Buy 57% Stake